CSBR:NASDAQ
Champions Oncology Inc
4,70 $
arrow_upward
+1,18%(+0,055) 1D
13 қар., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,57 $
High
4,70 $
Low
4,52 $
Mkt. cap
65,49 млн
Avg. vol.
8,16 мың
Volume
0,00
52-wk high
8,31 $
52-wk low
4,52 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,57 $
High
4,70 $
Low
4,52 $
Mkt. cap
65,49 млн
Avg. vol.
8,16 мың
Volume
0,00
52-wk high
8,31 $
52-wk low
4,52 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
MarketWatch
·
1 сағат бұрын
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
Investing.com
·
56 минут бұрын
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
The Motley Fool
·
2 сағат бұрын
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Billionaires.Africa
·
11 минут бұрын
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью-Джерси, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com